BiotechTube

1% Colloidal Oatmeal Balm

Pre-clinicalTerminated
0 views this week 0 watching💤 Quiet
Interest: 18/100
18
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Eczema

Conditions

Eczema

Trial Timeline

Mar 1, 2015 → Mar 1, 2016

NCT ID
NCT02404493

About 1% Colloidal Oatmeal Balm

1% Colloidal Oatmeal Balm is a pre-clinical stage product being developed by Johnson & Johnson for Eczema. The current trial status is terminated. This product is registered under clinical trial identifier NCT02404493. Target conditions include Eczema.

What happened to similar drugs?

2 of 13 similar drugs in Eczema were approved

Approved (2) Terminated (2) Active (9)
🔄Colloidal Oatmeal CreamJohnson & JohnsonPhase 3
✅Pimecrolimus cream 1%NovartisApproved
🔄AbrocitinibPfizerPhase 3
🔄alitretinoin + PlaceboGSK plcPhase 3
✅DupilumabRegeneron PharmaceuticalsApproved
❌Ruxolitinib cream + VehicleIncytePhase 3
❌Ruxolitinib cream + VehicleIncytePhase 3

Hype Score Breakdown

Clinical
3
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02404493Pre-clinicalTerminated

Competing Products

20 competing products in Eczema

See all competitors
ProductCompanyStageHype Score
Colloidal Oatmeal CreamJohnson & JohnsonPhase 3
40
Pimecrolimus cream 1%NovartisApproved
43
AbrocitinibPfizerPhase 3
47
Dupilumab + PlaceboSanofiPhase 2
31
Amlitelimab + PlaceboSanofiPhase 2
35
alitretinoin + PlaceboGSK plcPhase 3
40
DupilumabRegeneron PharmaceuticalsApproved
39
Adventan® (methylprednisolone aceponate 0,1%)BayerPhase 1
26
Ruxolitinib cream + VehicleIncytePhase 3
29
Ruxolitinib cream + VehicleIncytePhase 2
32
Ruxolitinib cream + VehicleIncytePhase 3
29
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%Arcutis BiotherapeuticsPhase 3
34
Roflumilast Cream + Vehicle creamArcutis BiotherapeuticsPhase 3
34
ARQ-151 cream 0.05%Arcutis BiotherapeuticsPhase 2
29
Roflumilast Cream 0.05% + Vehicle CreamArcutis BiotherapeuticsPhase 3
34
Roflumilast Cream 0.15% + Vehicle CreamArcutis BiotherapeuticsPhase 3
34
ARQ-151 cream 0.15% + ARQ-151 cream 0.05%Arcutis BiotherapeuticsPhase 1
23
ARQ-252 cream 0.3% + ARQ-252 cream 0.1% + ARQ-252 Vehicle CreamArcutis BiotherapeuticsPhase 1/2
26
LAS41003 + LAS189962 + LAS189961AlmirallPhase 2
29
LAS 41002 + ActiveAlmirallPhase 2
29